Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Zoetis Common Stock Net 2011-2025 | ZTS

Zoetis common stock net from 2011 to 2025. Common stock net can be defined as the value of common equity ownership.
  • Zoetis common stock net for the quarter ending March 31, 2025 was $5M, a 0% increase year-over-year.
  • Zoetis common stock net for 2024 was $0.005B, a 0% decline from 2023.
  • Zoetis common stock net for 2023 was $0.005B, a 0% decline from 2022.
  • Zoetis common stock net for 2022 was $0.005B, a 0% decline from 2021.
  
Zoetis Annual Common Stock Net
(Millions of US $)
2024 $5
2023 $5
2022 $5
2021 $5
2020 $5
2019 $5
2018 $5
2017 $5
2016 $5
2015 $5
2014 $5
2013 $5
2012 $4,183
2011 $3,785
2010 $0
Zoetis Quarterly Common Stock Net
(Millions of US $)
2025-03-31 $5
2024-12-31 $5
2024-09-30 $5
2024-06-30 $5
2024-03-31 $5
2023-12-31 $5
2023-09-30 $5
2023-06-30 $5
2023-03-31 $5
2022-12-31 $5
2022-09-30 $5
2022-06-30 $5
2022-03-31 $5
2021-12-31 $5
2021-09-30 $5
2021-06-30 $5
2021-03-31 $5
2020-12-31 $5
2020-09-30 $5
2020-06-30 $5
2020-03-31 $5
2019-12-31 $5
2019-09-30 $5
2019-06-30 $5
2019-03-31 $5
2018-12-31 $5
2018-09-30 $5
2018-06-30 $5
2018-03-31 $5
2017-12-31 $5
2017-09-30 $5
2017-06-30 $5
2017-03-31 $5
2016-12-31 $5
2016-09-30 $5
2016-06-30 $5
2016-03-31 $5
2015-12-31 $5
2015-09-30 $5
2015-06-30 $5
2015-03-31 $5
2014-12-31 $5
2014-09-30 $5
2014-06-30 $5
2014-03-31 $5
2013-12-31 $5
2013-09-30 $5
2013-06-30 $5
2013-03-31 $5
2012-12-31 $4,183
2012-09-30 $0
2012-06-30 $0
2012-03-31 $0
2011-12-31 $0
2010-12-31 $0
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $68.299B $9.256B
Zoetis Inc. is a leader in the animal health space with a focus on both livestock and companion animals in seven major product categories: vaccines, anti-infectives, parasiticides, dermatology, other pharmaceutical products, medicated feed additives and animal health diagnostics. Zoetis has a diversified business, which caters to eight core species ' cattle, swine, poultry, fish and sheep (collectively, livestock) and dogs, cats and horses (collectively, companion animals). It directly markets its products to veterinarians and livestock producers. The outstanding growth rate in the companion animal medicines, vaccines and diagnostics sector is being driven by economic development, related increases in disposable income and a rise in pet ownership and spending on pet care.Zoetis has been working on strengthening its product portfolio through acquisitions and deals.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $70.033B 26.94
Takeda Pharmaceutical (TAK) Japan $47.729B 9.74
Daiichi Sankyo, - (DSNKY) Japan $47.567B 24.38
BeOne Medicines - (ONC) Switzerland $35.221B 0.00
Sandoz Group AG (SDZNY) Switzerland $26.101B 0.00
Summit Therapeutics (SMMT) United States $19.827B 0.00
Merck (MKKGY) Germany $17.079B 11.10
Shionogi (SGIOY) Japan $15.193B 0.00
United Therapeutics (UTHR) United States $14.124B 12.22
Neurocrine Biosciences (NBIX) United States $13.181B 39.32
Orion OYJ (ORINY) Finland $10.848B 26.14
IPSEN (IPSEY) France $10.601B 0.00
Eisai (ESAIY) $9.204B 10.38
Madrigal Pharmaceuticals (MDGL) United States $8.212B 0.00
Corcept Therapeutics (CORT) United States $7.560B 63.49
Grifols, S.A (GRFS) Spain $7.371B 0.00
Ionis Pharmaceuticals (IONS) United States $6.978B 0.00
Stevanato Group S.p.A (STVN) Italy $6.850B 40.39
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.317B 0.00
Ono Pharmaceutical (OPHLF) Japan $5.141B 17.65
Soleno Therapeutics (SLNO) United States $3.807B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.968B 14.10
Crinetics Pharmaceuticals (CRNX) United States $2.893B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $2.824B 0.00
Hypermarcas (HYPMY) Brazil $2.676B 20.12
Catalyst Pharmaceuticals (CPRX) United States $2.476B 8.29
Centessa Pharmaceuticals (CNTA) United Kingdom $2.417B 0.00
Ocular Therapeutix (OCUL) United States $2.196B 0.00
Dyne Therapeutics (DYN) United States $1.761B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.757B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.615B 24.06
Guardian Pharmacy Services (GRDN) United States $1.495B 0.00
Ardelyx (ARDX) United States $1.439B 0.00
Harrow (HROW) United States $1.436B 0.00
ARS Pharmaceuticals (SPRY) United States $1.436B 0.00
Evotec AG (EVO) Germany $1.335B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $1.329B 0.00
Xeris Biopharma Holdings (XERS) United States $1.240B 0.00
Enliven Therapeutics (ELVN) United States $1.198B 0.00
Collegium Pharmaceutical (COLL) United States $1.189B 6.50
Cronos Group (CRON) Canada $0.908B 0.00
Akebia Therapeutics (AKBA) United States $0.862B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.713B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.709B 7.30
ProKidney (PROK) United States $0.691B 0.00
Theravance Biopharma (TBPH) United States $0.662B 54.79
KalVista Pharmaceuticals (KALV) United States $0.643B 0.00
Relay Therapeutics (RLAY) United States $0.610B 0.00
Bioventus (BVS) United States $0.609B 14.74
Siga Technologies (SIGA) United States $0.609B 7.52
Organogenesis (ORGO) United States $0.600B 0.00
Elite Pharmaceuticals (ELTP) United States $0.581B 0.00
Tourmaline Bio (TRML) United States $0.580B 0.00
Oruka Therapeutics (ORKA) United States $0.576B 0.00
USANA Health Sciences (USNA) United States $0.555B 11.39
Xencor (XNCR) United States $0.548B 0.00
Zevra Therapeutics (ZVRA) United States $0.529B 0.00
Savara (SVRA) United States $0.525B 0.00
Nektar Therapeutics (NKTR) United States $0.518B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.450B 0.00
Esperion Therapeutics (ESPR) United States $0.413B 0.00
Aquestive Therapeutics (AQST) United States $0.410B 0.00
Nanobiotix S.A (NBTX) France $0.379B 0.00
4D Molecular Therapeutics (FDMT) United States $0.339B 0.00
Larimar Therapeutics (LRMR) United States $0.332B 0.00
Aldeyra Therapeutics (ALDX) United States $0.323B 0.00
Altimmune (ALT) United States $0.320B 0.00
AleAnna (ANNA) United States $0.293B 0.00
Nature's Sunshine Products (NATR) United States $0.292B 19.01
OmniAb (OABI) United States $0.247B 0.00
Galectin Therapeutics (GALT) United States $0.229B 0.00
Heron Therapeutics (HRTX) United States $0.204B 0.00
Lyell Immunopharma (LYEL) United States $0.203B 0.00
Aclaris Therapeutics (ACRS) United States $0.203B 0.00
MediWound (MDWD) Israel $0.196B 0.00
Korro Bio (KRRO) United States $0.190B 0.00
China SXT Pharmaceuticals (SXTC) China $0.186B 0.00
Innate Pharma SA (IPHYF) France $0.173B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.167B 25.75
Journey Medical (DERM) United States $0.162B 0.00
MEI Pharma (MEIP) United States $0.158B 0.00
Lexeo Therapeutics (LXEO) United States $0.157B 0.00
Avita Medical (RCEL) United States $0.150B 0.00
Achieve Life Sciences (ACHV) Canada $0.130B 0.00
Inhibikase Therapeutics (IKT) United States $0.130B 0.00
Profound Medical (PROF) Canada $0.128B 0.00
Avalo Therapeutics (AVTX) United States $0.119B 0.00
Protara Therapeutics (TARA) United States $0.117B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.113B 0.00
Cassava Sciences (SAVA) United States $0.113B 0.00
Cardiol Therapeutics (CRDL) Canada $0.110B 0.00
Liminatus Pharma (LIMN) United States $0.104B 0.00
Dominari Holdings (DOMH) United States $0.098B 0.00
Surrozen (SRZN) United States $0.095B 0.00
ESSA Pharma (EPIX) Canada $0.091B 0.00
Champions Oncology (CSBR) United States $0.090B 20.38
BioNxt Solutions (BNXTF) Canada $0.086B 0.00
VAXART, INC (VXRT) United States $0.084B 0.00
PMV Pharmaceuticals (PMVP) United States $0.081B 0.00
Arch Biopartners (ACHFF) Canada $0.080B 0.00
Assertio Holdings (ASRT) United States $0.078B 0.00
Pyxis Oncology (PYXS) United States $0.076B 0.00
Vivani Medical (VANI) United States $0.074B 0.00
Nutriband (NTRB) United States $0.073B 0.00
Context Therapeutics (CNTX) United States $0.071B 0.00
Metagenomi (MGX) United States $0.070B 0.00
Inotiv (NOTV) United States $0.065B 0.00
Gain Therapeutics (GANX) United States $0.062B 0.00
Unicycive Therapeutics (UNCY) United States $0.059B 0.00
DURECT (DRRX) United States $0.059B 0.00
Rafael Holdings (RFL) United States $0.058B 0.00
Procaps Group, S.A (PROCF) Luxembourg $0.058B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.056B 0.00
PolyPid (PYPD) Israel $0.055B 0.00
Karyopharm Therapeutics (KPTI) United States $0.051B 0.00
Fractyl Health (GUTS) United States $0.051B 0.00
NRx Pharmaceuticals (NRXP) United States $0.050B 0.00
Prelude Therapeutics (PRLD) United States $0.049B 0.00
Century Therapeutics (IPSC) United States $0.048B 0.00
Wellgistics Health (WGRX) United States $0.047B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.047B 28.45
Tempest Therapeutics (TPST) United States $0.047B 0.00
Telomir Pharmaceuticals (TELO) United States $0.044B 0.00
Enlivex Therapeutics (ENLV) Israel $0.043B 0.00
Jupiter Neurosciences (JUNS) United States $0.043B 0.00
Acrivon Therapeutics (ACRV) United States $0.042B 0.00
ElectroCore (ECOR) United States $0.040B 0.00
Klotho Neurosciences (KLTO) United States $0.040B 0.00
Iterum Therapeutics (ITRM) Ireland $0.039B 0.00
FibroGen (FGEN) United States $0.038B 0.00
Plus Therapeutics (PSTV) United States $0.038B 0.00
SCYNEXIS (SCYX) United States $0.035B 0.00
Mural Oncology (MURA) Ireland $0.030B 0.00
CASI Pharmaceuticals (CASI) China $0.029B 0.00
Cosmos Health (COSM) United States $0.027B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.026B 0.00
Vivos Therapeutics (VVOS) United States $0.024B 0.00
Natural Alternatives (NAII) United States $0.024B 0.00
Relmada Therapeutics (RLMD) United States $0.021B 0.00
Scienture Holdings (SCNX) United States $0.020B 0.00
Mannatech (MTEX) United States $0.017B 0.00
Lipocine (LPCN) United States $0.016B 0.00
Ainos (AIMD) United States $0.016B 0.00
BioLineRx (BLRX) Israel $0.016B 0.00
ProPhase Labs (PRPH) United States $0.015B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.014B 0.00
Citius Pharmaceuticals (CTXR) United States $0.014B 0.00
TherapeuticsMD (TXMD) United States $0.014B 0.00
Carisma Therapeutics (CARM) United States $0.012B 0.00
Ernexa Therapeutics (ERNA) United States $0.012B 0.00
Lyra Therapeutics (LYRA) United States $0.012B 0.00
Incannex Healthcare (IXHL) Australia $0.011B 0.00
Heatwurx (PCSA) United States $0.011B 0.00
Traws Pharma (TRAW) United States $0.011B 0.02
Phio Pharmaceuticals (PHIO) United States $0.010B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.010B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.009B 0.00
TransCode Therapeutics (RNAZ) United States $0.009B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.009B 0.00
Talphera (TLPH) United States $0.009B 0.00
Mangoceuticals (MGRX) United States $0.008B 0.00
Addex Therapeutics (ADXN) Switzerland $0.008B 0.00
Biomerica (BMRA) United States $0.008B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.008B 0.00
Aptorum Group (APM) United Kingdom $0.007B 0.00
Nuvilex (PMCB) United States $0.006B 0.00
VYNE Therapeutics (VYNE) United States $0.005B 0.00
Conduit Pharmaceuticals (CDT) United States $0.005B 0.00
InMed Pharmaceuticals (INM) Canada $0.005B 0.00
Xenetic Biosciences (XBIO) United States $0.004B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.004B 0.00
Clearmind Medicine (CMND) Canada $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.004B 0.00
Indaptus Therapeutics (INDP) United States $0.004B 0.00
Jaguar Animal Health (JAGX) United States $0.004B 0.00
Alaunos Therapeutics (TCRT) United States $0.004B 0.00
Redhill Biopharma (RDHL) Israel $0.003B 0.00
Qualigen Therapeutics (QLGN) United States $0.003B 0.00
CERo Therapeutics Holdings (CERO) United States $0.003B 0.00
BioVie (BIVI) United States $0.003B 0.00
PainReform (PRFX) Israel $0.003B 0.00
SciSparc (SPRC) Israel $0.002B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
SHINECO (SISI) China $0.002B 0.00
Aditxt (ADTX) United States $0.002B 0.00
Universe Pharmaceuticals INC (UPC) China $0.002B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.002B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.001B 0.00
TNF Pharmaceuticals (TNFA) United States $0.001B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.001B 0.00
Indivior (INDV) United States $0.000B 13.18
4D Pharma (LBPS) United Kingdom $0.000B 0.00
Minerva Neurosciences (NERV) United States $0.000B 1.52
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Silence Therapeutics (SLN) United Kingdom $0.000B 0.00